Numira Biosciences of Salt Lake City, Utah, a specialty CRO in high-resolution, 3D imaging services and visualization software for the life science market, has acquired the efficacy pharmacology unit of Ricerca Biosciences of Bothell, Wash. The acquisition adds a GLP-compliant facility with a range of laboratory capabilities to Numira, which will be able to offer in-life models and studies, high-resolution quantitative imaging, histology and immunohistochemistry services.